129 related articles for article (PubMed ID: 23845437)
1. Linking MLL Leukemia with Integrin Signaling.
Zeisig BB; So CW
Cancer Cell; 2013 Jul; 24(1):5-7. PubMed ID: 23845437
[TBL] [Abstract][Full Text] [Related]
2. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.
Miller PG; Al-Shahrour F; Hartwell KA; Chu LP; Järås M; Puram RV; Puissant A; Callahan KP; Ashton J; McConkey ME; Poveromo LP; Cowley GS; Kharas MG; Labelle M; Shterental S; Fujisaki J; Silberstein L; Alexe G; Al-Hajj MA; Shelton CA; Armstrong SA; Root DE; Scadden DT; Hynes RO; Mukherjee S; Stegmaier K; Jordan CT; Ebert BL
Cancer Cell; 2013 Jul; 24(1):45-58. PubMed ID: 23770013
[TBL] [Abstract][Full Text] [Related]
3. Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish.
Tan J; Zhao L; Wang G; Li T; Li D; Xu Q; Chen X; Shang Z; Wang J; Zhou J
Biomed Res Int; 2018; 2018():6705842. PubMed ID: 30003105
[TBL] [Abstract][Full Text] [Related]
4. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
[TBL] [Abstract][Full Text] [Related]
5. Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner.
He S; Malik B; Borkin D; Miao H; Shukla S; Kempinska K; Purohit T; Wang J; Chen L; Parkin B; Malek SN; Danet-Desnoyers G; Muntean AG; Cierpicki T; Grembecka J
Leukemia; 2016 Feb; 30(2):508-13. PubMed ID: 26084867
[No Abstract] [Full Text] [Related]
6. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
[TBL] [Abstract][Full Text] [Related]
7. Functional inactivation of P53 as a potential mechanism of MLL leukemogenesis.
Wiederschain D; Yuan ZM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):617-20. PubMed ID: 17062917
[TBL] [Abstract][Full Text] [Related]
8. Reconstructing the disease model and epigenetic networks for MLL-AF4 leukemia.
Zeisig BB; Cheung N; Yeung J; So CW
Cancer Cell; 2008 Nov; 14(5):345-7. PubMed ID: 18977321
[TBL] [Abstract][Full Text] [Related]
9. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
10. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
Chen Y; Anastassiadis K; Kranz A; Stewart AF; Arndt K; Waskow C; Yokoyama A; Jones K; Neff T; Lee Y; Ernst P
Cancer Cell; 2017 Jun; 31(6):755-770.e6. PubMed ID: 28609655
[TBL] [Abstract][Full Text] [Related]
11. The ongoing conundrum of MLL-AF4 driven leukemogenesis.
Stam RW
Blood; 2013 May; 121(19):3780-1. PubMed ID: 23660854
[No Abstract] [Full Text] [Related]
12. Molecular pathogenesis of MLL-associated leukemias.
Eguchi M; Eguchi-Ishimae M; Greaves M
Int J Hematol; 2005 Jul; 82(1):9-20. PubMed ID: 16105754
[TBL] [Abstract][Full Text] [Related]
13. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X
Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607
[TBL] [Abstract][Full Text] [Related]
14. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.
Ono R; Kumagai H; Nakajima H; Hishiya A; Taki T; Horikawa K; Takatsu K; Satoh T; Hayashi Y; Kitamura T; Nosaka T
Leukemia; 2009 Dec; 23(12):2197-209. PubMed ID: 19710696
[TBL] [Abstract][Full Text] [Related]
15. MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.
Horton SJ; Jaques J; Woolthuis C; van Dijk J; Mesuraca M; Huls G; Morrone G; Vellenga E; Schuringa JJ
Leukemia; 2013 Apr; 27(5):1116-26. PubMed ID: 23178754
[TBL] [Abstract][Full Text] [Related]
16. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
Daser A; Rabbitts TH
Genes Dev; 2004 May; 18(9):965-74. PubMed ID: 15132992
[No Abstract] [Full Text] [Related]
17. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
[TBL] [Abstract][Full Text] [Related]
18. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
19. The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.
Johansen S; Brenner AK; Bartaula-Brevik S; Reikvam H; Bruserud Ø
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342970
[TBL] [Abstract][Full Text] [Related]
20. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
